成人Still病继发AA淀粉样变:19例分析
本文报告3例法国成人Still病(AOSD)继发AA淀粉样变(AAA)病例,并系统检索1971至2018年MEDLINE文献,共评估19例患者。AOSD相关AAA患病率为0.88%(95%CI [0.49-1.28]),从AOSD起病至AAA诊断平均延迟16.75±5.8年,肾脏受累最常见,多数患者在AAA诊断时AOSD仍处于活动期。
要点
- AOSD相关AAA患病率为0.88%(95%CI [0.49-1.28])
- AAA诊断时多数患者AOSD仍活动,肾脏受累最常见
- AOSD起病至AAA诊断平均延迟16.75±5.8年
核心结论
- AAA是AOSD病程中罕见且严重的并发症,可发生于未控制的活跃性AOSD患者。
- 早期诊断和更好地控制AOSD(包括更频繁使用生物制剂)可能有助于预防AAA。
研究设计与样本
- 系统检索MEDLINE 1971至2018年文献,由两名独立研究者筛选AOSD并发AAA的报告。
- 通过法国罕见自身炎症性疾病与淀粉样变参考中心(CEREMAIA)补充3例新法国病例,排除幼年特发性关节炎患者。
- 基于45篇文章计算AOSD相关AAA患病率,并对3例新病例加16例文献患者共19例评估临床表现、危险因素和治疗反应。
主要发现
- AOSD相关AAA患病率为0.88%(95%CI [0.49-1.28])。
- AOSD起病平均年龄29.6±12.6岁,AAA诊断前平均延迟16.75±5.8年。
- 肾脏受累是AAA最常见的表现。
- 多数患者在AAA诊断时AOSD仍处于活动期。
关键数值与推荐
- AOSD相关AAA患病率0.88%(95%CI [0.49-1.28]),基于45篇文章。
- AOSD起病平均年龄29.6±12.6岁。
- AAA诊断前平均延迟16.75±5.8年。
临床怎么用
- 对病程长、疾病活动未控制的AOSD患者应警惕AAA,注意评估肾脏受累。
- 早期诊断和更好地控制AOSD活动(包括更频繁使用生物制剂)可能有助于预防AAA。
- AOSD相关AAA的治疗曾尝试糖皮质激素和生物制剂等多种方案。
局限性
- 本文未报告所纳入19例患者的样本量细节、各治疗的具体疗效数据及统计学比较结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Adult onset Still's disease (AOSD) is an inflammatory disorder characterized by high spiking fever, evanescent rash, polyarthritis, and many other systemic manifestations. Recurrent or persistent disease can lead to AA amyloidosis (AAA). Our objectives were to present 3 French cases and perform a systematic review of the literature, in order to determine the prevalence, characteristics, predisposing factors, and therapeutic response of AOSD-related AAA. METHODS: A systematic literature review was performed by searching MEDLINE from 1971 to 2018. Two independent investigators selected reports of AAA complicating AOSD. New French cases were identified with the help of the Reference Center for rare Auto-Inflammatory Diseases and Amyloidosis (CEREMAIA). Patients with juvenile idiopathic arthritis were excluded. RESULTS: The prevalence of AAA in AOSD was 0.88% (95%CI [0.49-1.28]) based on 45 articles. In addition to 3 new cases from the CEREMAIA, 16 patients were assessed for clinical presentation, risk factors, and therapeutic response of AOSD-related AAA. Mean age at AOSD onset was 29.6 ± 12.6 years, with a mean delay before AAA diagnosis of 16.75±5.8 years. Renal involvement was the most common manifestation of AAA. The majority of patients presented active AOSD at AAA diagnosis. Various treatments of AOSD-related AAA were attempted including corticosteroids and biotherapies. CONCLUSION: AAA is a rare and severe complication that may occur during the course of uncontrolled active AOSD. It could be prevented by early diagnosis and better control of AOSD, with more frequent use of biotherapies.
引用
- Delplanque M, Pouchot J, Ducharme-Bénard S, et al. AA amyloidosis secondary to adult onset Still's disease: About 19 cases. Semin Arthritis Rheum. 2019. PMID: 31488308. doi:10.1016/j.semarthrit.2019.08.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。